Three Bridge Wealth Advisors’s Immunome IMNM Stock Holding History

Three Bridge Wealth Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$164K	Buy	+7,615	New	+$189K	0.03%	99
2026 Q2	–	Sell	-37,615	Closed	-$823K	–	92
2026 Q1	$823K	Hold	37,615	–	–	0.23%	45
2025 Q4	$808K	Hold	37,615	–	–	0.21%	44
2025 Q3	$440K	Hold	37,615	–	–	0.11%	64
2025 Q2	$350K	Hold	37,615	–	–	0.09%	80
2025 Q1	$253K	Buy	37,615 +10,000	+36%	+$95.9K	0.09%	76
2024 Q4	$293K	Buy	+27,615	New	+$334K	0.1%	75

Other funds holding IMNM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Three Bridge Wealth Advisors's IMNM Position: Q3 2026 in Review

Three Bridge Wealth Advisors opened a new position in Immunome (IMNM) in Q3 2026: 7,615 shares worth $164K. The stake represents 0.03% of the portfolio and ranks #99 among its holdings. This is a return to the name: Three Bridge Wealth Advisors previously reported a position in IMNM as recently as Q1 2026.

Three Bridge Wealth Advisors first reported a position in IMNM in Q4 2024 and has held it in 7 quarters since. The position peaked at $823K in Q1 2026. 65 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

Three Bridge Wealth Advisors held 7,615 shares of Immunome worth $164K as of Q3 2026.
Immunome was a new Three Bridge Wealth Advisors position in Q3 2026.
Immunome made up 0.03% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #99 holding.
Three Bridge Wealth Advisors first reported a position in Immunome in Q4 2024 and has held it in 7 quarters since.
Three Bridge Wealth Advisors's Immunome position peaked at $823K in Q1 2026.
65 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.